Severs disease, also known as calcaneal apophysitis, is a common cause of heel pain in children. It occurs due to inflammation of the growth plate in the heel bone. The common symptoms include pain in heel while walking, running or jumping. increasing participation in various sports activities among children has significantly contributed to the rising prevalence of Severs disease. Orthopedic treatments aim to relieve pain and correct heel alignment. Non-steroidal anti-inflammatory drugs (NSAIDs) are primarily used to reduce inflammation in the affected area. Physical therapy involves exercises to stretch the Achilles tendon and calf muscles. Orthotics or shoe inserts are also used to correct foot mechanics. The growing awareness about the effectiveness of these treatments is propelling the market growth.

The Global Severs Disease Treatment Market is estimated to be valued at US$ 1.34 Bn in 2024 and is expected to exhibit a CAGR of 4.9% over the forecast period 2024 To 2031.

Key Takeaways

Key players operating in the Severs disease treatment market are AstraZeneca , Horizon Therapeutics plc, Sanofi, Novartis AG, Sun Pharmaceutical Industries Ltd., Cipla Inc., LEO Pharma A/S, AbbVie Inc., Mylan N.V., Teva Pharmaceutical Industries Ltd., Aurobindo Pharma, Lonza, Lupin, Dr. Reddy’s Laboratories Ltd., IBSA Institut Biochimique SA.

The rising incidence of Severs Disease Treatment Market Size among children and adolescents due to increased participation in sports activities is a major factor fueling the demand for treatment options.

Technological advancements in orthopedic products such as biodegradable implants, 3D printed orthotics and infection resistant materials are expanding the treatment opportunities for Severs disease.

Market Trends

Growing demand for minimally invasive treatments

The development of minimally invasive procedures such as arthroscopic surgeries reduce recovery time and risk of complications. This is boosting the adoption of such techniques for Severs disease treatment.

Increased adoption of combination therapy

Combining pharmacotherapy, physiotherapy and orthotic management is found to be more effective than single modality treatment. The trend of combination therapy is gaining prominence.

Market Opportunities

Untapped developing regions

There is significant unmet need for Severs disease treatment in developing countries due to lack of availability and awareness. Penetration in these regions provides major opportunities.

New product launches

R&D initiatives aimed at developing novel drug formulations, advanced orthotics and combination therapy regimens can further expand the treatment options.

Impact of COVID-19 on Severs Disease Treatment Market

The COVID-19 pandemic has significantly impacted the global Severs Disease Treatment market. During the initial outbreak, various restrictions were imposed which led to temporary closure of manufacturing facilities and disrupted the supply chain. This negatively affected the production and distribution of Severs disease treatment drugs. However, with the classification of these drugs as essential medicines, their production and supply were continued with necessary safety protocols. But the decreased outpatient visits and postponed elective surgeries reduced the demand for Severs disease treatment drugs in 2020.

While the restrictions have eased now in many parts of the world, the fear of virus transmission has changed patient behavior. People are still hesitant in visiting hospitals and clinics for minor ailments like Severs disease unless absolutely necessary. Teleconsultations have gained prominence during this time but can't replace the need for physical examinations in many cases of Severs disease. Vaccinations are in progress but it will take time for complete normalization. The market is expected to gradually recover over the forecast period as concerns regarding COVID-19 recede. However, any future waves can again impact the market growth. Pharma companies will need to focus on enhancing supply chain resilience and adaptability in these uncertain times.

North America dominates the global Severs disease treatment market in terms of revenue. This is majorly contributed by the US where diagnosis and treatment rates are highest attributed to factors like sedentary lifestyle, less physical activity among kids and awareness levels regarding Severs disease.

Asia Pacific region is poised to be the fastest growing market for Severs disease treatment. Rising health awareness, growing disposable incomes, increasing medical tourism and improving access to healthcare are some key factors fueling the market growth in emerging economies of China and India. Initiatives by governments to strengthen public healthcare infrastructure will further support market expansion in Asia Pacific over the coming years.

Get more insights on Severs Disease Treatment Market